Clearpoint Neuro is trading at $10.18, up 5.01%, with no confirmed catalyst identified for the October 28 move.

  • The company is scheduled to report third-quarter results after the market close, followed by an investor call at 4:30 p.m. ET; this timing alone does not explain the gain.
  • A law firm announced an investor investigation on October 27, but available coverage does not link it to the October 28 rise.
  • Market indices are mixed, offering no clear broad-market explanation.